BlackRock Fund Advisors - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$180,125,000
+11.4%
1,772,705
+11.9%
0.03%0.0%
Q3 2016$161,744,000
-7.5%
1,584,794
+8.1%
0.03%
-15.4%
Q2 2016$174,906,000
+18.6%
1,466,467
+6.5%
0.04%
+14.7%
Q1 2016$147,463,000
+0.5%
1,377,004
+1.8%
0.03%0.0%
Q4 2015$146,696,000
+26.6%
1,353,035
+0.0%
0.03%
+13.3%
Q3 2015$115,844,000
-10.2%
1,352,528
+5.8%
0.03%
-3.2%
Q2 2015$128,938,000
+25.4%
1,277,878
-4.1%
0.03%
+24.0%
Q1 2015$102,788,000
+51.3%
1,333,008
+4.4%
0.02%
+47.1%
Q4 2014$67,951,000
+16.6%
1,277,041
+2.9%
0.02%
+6.2%
Q3 2014$58,298,000
-27.9%
1,240,648
-4.5%
0.02%
-30.4%
Q2 2014$80,909,000
-11.2%
1,298,901
-4.1%
0.02%
-14.8%
Q1 2014$91,151,000
+31.5%
1,355,000
+2.8%
0.03%
+28.6%
Q4 2013$69,336,000
+120.8%
1,318,179
+81.7%
0.02%
+90.9%
Q3 2013$31,396,000
+32.8%
725,419
+14.8%
0.01%
+22.2%
Q2 2013$23,636,000631,9800.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders